Aptinyx (APTX) News Today → My system predicted the BA collapse – now it’s issuing an AI warning (From Chaikin Analytics) (Ad) Free APTX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock AnalysisEarningsInsider TradesSocial MediaStock AnalysisEarningsInsider TradesSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative April 23, 2024 | businesswire.comTentarix Biotherapeutics Announces the Appointment of Andrew D. Kidd, MD, CFA, as CEOMarch 12, 2024 | benzinga.comNew Leaf Venture Management III, L.L.C.'s Net WorthFebruary 9, 2024 | benzinga.comPatrick J Heron's Net WorthJanuary 13, 2024 | cnet.comBest Noise-Canceling Headphones for 2024December 17, 2023 | morningstar.comAptinyx Inc APTXSeptember 7, 2023 | morningstar.comNorth American Morning Briefing: Concerns About -2-March 30, 2023 | finance.yahoo.comHere's Why Aptinyx Inc. (APTX) Is a Great 'Buy the Bottom' Stock NowFebruary 27, 2023 | finance.yahoo.comAptinyx Reports Results from Phase 2 Study of NYX-458 in Cognitive Impairment Associated with Parkinson's Disease and Dementia with Lewy Bodies and Provides Pipeline and Corporate UpdateFebruary 27, 2023 | marketbeat.comTrading was temporarily halted for "APTX" at 04:02 PM with a stated reason of "News pending."January 31, 2023 | finance.yahoo.comAptinyx to Present at the SVB Securities Global Biopharma ConferenceJanuary 16, 2023 | ca.finance.yahoo.comAptinyx Inc. (APTX) Stock Historical Prices & Data - Yahoo FinanceJanuary 5, 2023 | fool.comAptinyx (NASDAQ: APTX)December 30, 2022 | insidermonkey.comAptinyx Inc. (NASDAQ:APTX) Q3 2022 Earnings Call TranscriptDecember 12, 2022 | markets.businessinsider.comH.C. Wainwright Keeps Their Buy Rating on Aptinyx (APTX)November 8, 2022 | finance.yahoo.comAptinyx Reports Third Quarter 2022 Financial Results and Recent HighlightsOctober 30, 2022 | fool.comAptinyx Inc. (NASDAQ: APTX)October 18, 2022 | finance.yahoo.comAptinyx to Report Third Quarter 2022 Financial Results on Tuesday, November 8, 2022October 2, 2022 | reuters.comAPTX.OQ - Aptinyx Inc | Stock Price & Latest News | ReutersSeptember 24, 2022 | finance.yahoo.comAptinyx Inc. (APTX)September 12, 2022 | nasdaq.comHopeful week for insiders who might be regretting buying US$567k of Aptinyx Inc. (NASDAQ:APTX) stock earlier this year - NasdaqAugust 26, 2022 | marketscreener.comHC Wainwright Adjusts Price Target on Aptinyx to $1 From $2, Reiterates Buy Rating - Marketscreener.comAugust 25, 2022 | businesswire.comAptinyx Completes Enrollment in Phase 2 Study of NYX-458 in Cognitive Impairment Associated with Parkinson's Disease and Dementia with Lewy Bodies - Business WireAugust 25, 2022 | finance.yahoo.comAptinyx Completes Enrollment in Phase 2 Study of NYX-458 in Cognitive Impairment Associated with Parkinson’s Disease and Dementia with Lewy BodiesAugust 22, 2022 | finance.yahoo.comBullish Aptinyx Inc. (NASDAQ:APTX) investors are yet to receive a pay off on their US$567k betAugust 19, 2022 | nasdaq.comBiotech Stock Roundup: GILD's Drug News, NVAX & MRNA COVID-19 Vaccine Updates - NasdaqAugust 17, 2022 | morningstar.comNorth American Morning Briefing: Investors Seek -2- - MorningstarAugust 16, 2022 | markets.businessinsider.comWhat 4 Analyst Ratings Have To Say About AptinyxAugust 15, 2022 | marketscreener.comTruist Downgrades Aptinyx to Hold From Buy - Marketscreener.comAugust 12, 2022 | benzinga.comRecap Of Friday’s Biotech Catalysts - End Of the Day Summary - BenzingaAugust 12, 2022 | marketwatch.comAptinyx: Fibromyalgia-Pain Drug Trial Misses Endpoints - MarketWatchAugust 12, 2022 | finance.yahoo.comAptinyx's Chronic Pain Candidate Fails To Top Placebo In Mid-Stage StudyAugust 12, 2022 | businesswire.comAptinyx Reports Results from Phase 2b Study of NYX-2925 in Fibromyalgia - Business WireAugust 12, 2022 | finance.yahoo.comAptinyx Reports Results from Phase 2b Study of NYX-2925 in FibromyalgiaAugust 12, 2022 | marketbeat.comTrading was temporarily halted for "APTX" at 07:08 AM with a stated reason of "News pending."August 6, 2022 | fool.comAptinyx Inc. (APTX) Q2 2022 Earnings Call Transcript - The Motley FoolAugust 6, 2022 | fool.comAptinyx Inc. (APTX) Q2 2022 Earnings Call TranscriptAugust 5, 2022 | finance.yahoo.comAptinyx Reports Second Quarter 2022 Financial Results and Recent Highlights - Yahoo FinanceAugust 4, 2022 | seekingalpha.comAptinyx GAAP EPS of -$0.26 beats by $0.02 (NASDAQ:APTX) - Seeking AlphaAugust 4, 2022 | businesswire.comAptinyx Reports Second Quarter 2022 Financial Results and Recent Highlights - Business WireJuly 16, 2022 | gurufocus.comAptinyx to Report Second Quart - GuruFocus.comJuly 15, 2022 | finance.yahoo.comAptinyx to Report Second Quarter 2022 Financial Results on Thursday, August 4, 2022July 13, 2022 | nasdaq.comU.S. Silica (SLCA) Wraps Up $100 Million Loan Repurchase - NasdaqJuly 13, 2022 | nasdaq.comTFII vs. CHRW: Which Stock Should Value Investors Buy Now? - NasdaqJuly 13, 2022 | nasdaq.comAll You Need to Know About Aptinyx Inc. (APTX) Rating Upgrade to Buy - NasdaqJuly 13, 2022 | nasdaq.comPhilips (PHG) Expands AI Portfolio With SmartSpeed Solution - NasdaqJuly 13, 2022 | nasdaq.comAmerica Movil (AMX) Q2 Earnings Decline Y/Y, Revenues Increase - NasdaqJuly 13, 2022 | nasdaq.comMGM Resorts (MGM) Announces Partnership With MLB Players - NasdaqJune 22, 2022 | finance.yahoo.comAptinyx to Participate in H.C. Wainwright 1st Annual Mental Health ConferenceMay 31, 2022 | marketscreener.comAPTINYX INC. : Submission of Matters to a Vote of Security Holders (form 8-K) - Marketscreener.comMay 31, 2022 | marketscreener.comAptinyx : Statement of Changes in Beneficial Ownership (Form 4) - Marketscreener.com Get Aptinyx News Delivered to You Automatically Sign up to receive the latest news and ratings for APTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Biden to Drop BOMBSHELL June 13th? (Ad)Biden’s days are numbered! According to a former CIA and Pentagon insider… He’s about to drop out of the presidential race on June 13th! Click here now to see his shocking evidence. APTX Media Mentions By Week APTX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. APTX News Sentiment▼0.000.56▲Average Medical News Sentiment APTX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. APTX Articles This Week▼00▲APTX Articles Average Week Get Aptinyx News Delivered to You Automatically Sign up to receive the latest news and ratings for APTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Context Therapeutics News Grifols News LAVA Therapeutics News Mainz Biomed News NLS Pharmaceutics News Pharvaris News Tiziana Life Sciences News Aclarion News Alpha Tau Medical News American Oncology Network News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:APTX) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersDid Intel Just Dethrone Nvidia?Chaikin AnalyticsRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressCharles Payne Demystifies OptionsUnstoppable ProsperityElon to Transform U.S. Economy? Porter & CompanyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aptinyx Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
